FT Space 2022 - Banner

Israeli astronaut to carry out 35 experiments on ISS

Stibbe tests out the CRISPR experiment in a lab. Credit: PR

Edinburgh, 25 January 2022. – Former fighter jet pilot, Eytan Stibbe, is scheduled to become the second Israeli astronaut and the first to go to the International Space Station (ISS) in March this year.

The Rakia mission will bring 35 scientific and technological experiments into space, based on their potential and possible economic impact.

AX1, led by Axiom Space, is to be manned by three private astronauts with Stibbe leading the mission. The project is partly sponsored by the Ramon Foundation, the Israel Space Agency and the Ministry of Innovation Science and Technology. The aim is to inspire the younger generation while advancing the Israeli space industry and improving life on Earth.

During his 10-day stay, Stibbe will perform various experiments, test innovative technologies and give science lectures in Hebrew. This will be the first time that Israeli children have access to the ISS in Hebrew. 

The experiments were designed by leading Israeli institutions, companies and hospitals. These include studies from the fields of medicine, astrophysics, biology, optics, communications, and agriculture among others. Some of the tests will be carried out on Stibbe himself, for example different physical analysis, visual function tests, needle-free blood tests as well as testing a special vest to protect him from radiation. Further experiments range from cosmic lightning through super-vegetables to “nano-ghosts” (nanometer-sized stem cells).

Check Also

Space Café Radio – on tour in Berlin – with Lynn Zoenen

In this Space Café Radio -  SpaceWatch.Global publisher Torsten Kriening spoke with Lynn Zoenen, Principal at Alpine Space Ventures at the 19th ESA Investment Forum 2022 in Berlin on Space Investments in Europe. The ESA Investor Forum is a high-profile event for space-related investment opportunities and connects start-ups and scale-ups from the ESA network with European investors.